In the field of cancer detection, technologies to analyze tumors using biomarkers circulating
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …

Liquid biopsy is a revolutionary strategy in cancer diagnosis and prognosis prediction, which
is used to analyze cancer cells or cancer‐derived products through biofluids such as blood …

The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

Cell–cell communication is an essential mechanism for the maintenance and development
of various organs, including the female reproductive system. Today, it is well-known that the …

Recent studies have revealed both the promise and challenges of targeting long non-coding
RNAs (lncRNAs) to diagnose and treat endometrial cancer (EC). LncRNAs are upregulated …

Colorectal cancer (CRC) is one of the most common cancers worldwide, being the third most
diagnosed in the world and the second deadliest. Solid biopsy provides an essential guide …

Endometrial cancer is the leading gynaecological malignancy in the western world and its
incidence is rising in tandem with the global epidemic of obesity. Early diagnosis is key to …

Precision oncology aims to tailor clinical decisions specifically to patients with the objective
of improving treatment outcomes. This can be achieved by leveraging omics information for …

Due to the anatomical continuity of the uterine cavity with the cervix, genomic exploitation of
material from routine Pap smears and other noninvasive sampling methods represent a …

Current diagnostics for EC are invasive and often painful. There is an urgent need for high-
quality randomised controlled trials to inform effective pain relief options. Premenopausal …